Search - tctmd.com

Displaying 1 - 20 of 151

Sort: Relevancy | Date

Presentation TCT 2025

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

The Future of Interatrial Shunting

Presenter: Josep Rodés-Cabau

October 27, 2025

Presentation TCT 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2024

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement

Presenter: Josep Rodés-Cabau

October 27, 2024

Presentation TCT 2023

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Presenter: Josep Rodés-Cabau

October 26, 2023

Presentation TCT 2023

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Presenter: Josep Rodés-Cabau

October 24, 2023

Presentation TCT 2022

The Last Words on Conduction Disturbances

Presenter: Josep Rodés-Cabau

September 17, 2022

Presentation TCT 2021

A Pressure Wire for Valve Implantation and Continuous Hemodynamic Monitoring During TAVR Procedures: Initial Experience with the SavvyWire

Presenter: Josep Rodés-Cabau

November 05, 2021

Presentation TCT 2021

Controversies Surrounding Transcatheter Devices: Durability, Anticoagulation, Conduction, and More

Presenter: Josep Rodés-Cabau

November 04, 2021

Presentation TVT 2019

V-Wave for HFrEF and HFpEF

Presenter: Josep Rodés-Cabau

June 15, 2019

Presentation TVT 2019

AltaValve: Attributes, Challenges, and Future Programs

Presenter: Josep Rodés-Cabau

June 14, 2019

Presentation TVT 2019

LAA Closure Technology: Current Standards and “Hot” Newcomers

Presenter: Josep Rodés-Cabau

June 14, 2019

Presentation TVT 2019

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Presenter: Josep Rodés-Cabau

June 13, 2019

Presentation TCT 2018

Regulatory Considerations for Transcatheter Tricuspid Valve Therapies

Presenter: Jaime Raben, Josep Rodés-Cabau, Bernard Vasseur

September 23, 2018

Presentation TCT 2018

Transcatheter Tricuspid Valve Therapies: Challenging Technologies and Clinical Trial Pathways

Presenter: Jaime Raben, Josep Rodés-Cabau

September 23, 2018

Presentation TCT 2018

Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

Case #7: A Case of Pure Non-Calcific Aortic Insufficiency Treated With TAVR

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

Case #6: Trans-Carotid TAVR Step-by-Step

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

Case #5: A Case in Which We Pushed the Envelope to Complete a Transfemoral TAVR

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Advertisement

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

The Future of Interatrial Shunting

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following Transcatheter Aortic Valve Replacement

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

The Last Words on Conduction Disturbances

A Pressure Wire for Valve Implantation and Continuous Hemodynamic Monitoring During TAVR Procedures: Initial Experience with the SavvyWire

Controversies Surrounding Transcatheter Devices: Durability, Anticoagulation, Conduction, and More

V-Wave for HFrEF and HFpEF

AltaValve: Attributes, Challenges, and Future Programs

LAA Closure Technology: Current Standards and “Hot” Newcomers

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Regulatory Considerations for Transcatheter Tricuspid Valve Therapies

Transcatheter Tricuspid Valve Therapies: Challenging Technologies and Clinical Trial Pathways

Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies

Case #7: A Case of Pure Non-Calcific Aortic Insufficiency Treated With TAVR

Case #6: Trans-Carotid TAVR Step-by-Step

Case #5: A Case in Which We Pushed the Envelope to Complete a Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content